Research Unit of Plastic Surgery, Odense University Hospital, Odense, Denmark.
Clinical Institute, University of Southern Denmark, Odense, Denmark.
Ann Surg. 2024 Jun 1;279(6):1008-1017. doi: 10.1097/SLA.0000000000006244. Epub 2024 Feb 19.
To examine health-related quality of life (HRQL) and satisfaction with appearance in patients who have undergone bariatric surgery (BS) with or without subsequent body contouring surgery (BCS) in relation to the general population normative for the BODY-Q.
The long-term impact of BS with or without BCS has not been established using rigorously developed and validated patient-reported outcome measures. The BODY-Q is a patient-reported outcome measure developed to measure changes in HRQL and satisfaction with appearance in patients with BS and BCS.
Prospective BODY-Q data were collected from 6 European countries (Denmark, the Netherlands, Finland, Germany, Italy, and Poland) from June 2015 to February 2022 in a cohort of patients who underwent BS. Mixed-effects regression models were used to analyze changes in HRQL and appearance over time between patients who did and did not receive BCS and to examine the impact of patient-level covariates on outcomes.
This study included 24,604 assessments from 5620 patients. BS initially led to improved HRQL and appearance scores throughout the first postbariatric year, followed by a gradual decrease. Patients who underwent subsequent BCS after BS experienced a sustained improvement in HRQL and appearance or remained relatively stable for up to 10 years postoperatively.
Patients who underwent BCS maintained an improvement in HRQL and satisfaction with appearance in contrast to patients who only underwent BS, who reported a decline in scores 1 to 2 years postoperatively. Our results emphasize the pivotal role that BCS plays in the completion of the weight loss trajectory.
使用经过严格开发和验证的患者报告结局测量工具,研究接受过减重手术(BS)和/或随后进行身体塑形手术(BCS)的患者的健康相关生活质量(HRQL)和对外观的满意度,与 BODY-Q 的一般人群正常值进行比较。
BS 联合或不联合 BCS 的长期影响尚未通过使用经过严格开发和验证的患者报告结局测量工具来确定。BODY-Q 是一种患者报告结局测量工具,用于测量接受 BS 和 BCS 的患者的 HRQL 和对外观的满意度变化。
本前瞻性研究于 2015 年 6 月至 2022 年 2 月在 6 个欧洲国家(丹麦、荷兰、芬兰、德国、意大利和波兰)的 6 个欧洲国家中,从接受 BS 的患者队列中收集 BODY-Q 数据。采用混合效应回归模型分析在接受和不接受 BCS 的患者之间,随时间推移的 HRQL 和外观变化,并检查患者水平协变量对结局的影响。
本研究共纳入了 5620 名患者的 24604 次评估。BS 最初导致术后第一年的 HRQL 和外观评分逐渐改善,随后逐渐下降。BS 后接受后续 BCS 的患者 HRQL 和外观持续改善,或在术后长达 10 年内保持相对稳定。
与仅接受 BS 的患者相比,接受 BCS 的患者 HRQL 和对外观的满意度保持改善,而后者在术后 1 至 2 年内报告评分下降。我们的结果强调了 BCS 在完成体重减轻轨迹方面的关键作用。